<?xml version="1.0" encoding="UTF-8"?>
<p>SARS-CoV-2 infections revealed some unique clinical characteristics that include targeting the lower airway which is evident by symptoms of upper respiratory tract including rhinorrhoea, sneezing and sore throat [
 <xref rid="B78-ijerph-17-05648" ref-type="bibr">78</xref>]. Chest computed tomography (CT) scans revealed pneumonia in most SARS-CoV-2 infected patients and several cases showed an infiltrate in the upper lung lobe, which is related to increasing dyspnea with hypoxemia [
 <xref rid="B28-ijerph-17-05648" ref-type="bibr">28</xref>,
 <xref rid="B78-ijerph-17-05648" ref-type="bibr">78</xref>,
 <xref rid="B112-ijerph-17-05648" ref-type="bibr">112</xref>]. 
 <xref rid="ijerph-17-05648-t004" ref-type="table">Table 4</xref> describes the full picture of COVID-19 clinical manifestation. Atypical symptoms include RNAemia, acute cardiac injury, ARDS and grand-glass opacities that lead to death [
 <xref rid="B113-ijerph-17-05648" ref-type="bibr">113</xref>]. It should be noted that COVID-19 manifestations such as fever, dyspnea, dry cough and bilateral ground-glass opacities in chest CT scans are similar to the previous 
 <italic>Betacoronavirus</italic>-related diseases [
 <xref rid="B113-ijerph-17-05648" ref-type="bibr">113</xref>,
 <xref rid="B114-ijerph-17-05648" ref-type="bibr">114</xref>]. Although gastrointestinal symptoms such as diarrhea were reported in SARS-CoV-2 infected patients, the similar gastrointestinal distress occurred in only a small percentage of MERS-CoV or SARS-CoV patients (
 <xref ref-type="fig" rid="ijerph-17-05648-f006">Figure 6</xref>) [
 <xref rid="B78-ijerph-17-05648" ref-type="bibr">78</xref>]. It was shown that severe cases were characterized by an increased inflammation due to both systemic and localized immune response activation [
 <xref rid="B78-ijerph-17-05648" ref-type="bibr">78</xref>,
 <xref rid="B115-ijerph-17-05648" ref-type="bibr">115</xref>]. Higher leukocyte numbers, significantly high blood concentrations of cytokines and chemokines were noted in these cases [
 <xref rid="B28-ijerph-17-05648" ref-type="bibr">28</xref>,
 <xref rid="B78-ijerph-17-05648" ref-type="bibr">78</xref>]. Hence, it is now accepted that high levels of proinflammatory cytokines could worsen the prognosis [
 <xref rid="B28-ijerph-17-05648" ref-type="bibr">28</xref>,
 <xref rid="B113-ijerph-17-05648" ref-type="bibr">113</xref>].
</p>
